Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Keil

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Clinical Investigation|June 20, 2014
Clofarabine/cyclophosphamide for debulking before stem cell transplantationWerner Rabitsch, Alexandra Böhm, Marija Bojic, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2021
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trialFelix Keil, Maximilian Hartl, Gabriela Altorjai, et al.
American Journal of Hematology|June 1, 2024
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALLKarin Bauer, Alexander Hauswirth, Karoline V Gleixner, et al.
Wiener Klinische Wochenschrift|December 14, 2018
Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy managementMaria-Theresa Krauth, Sonja Burgstaller, Veronika Buxhofer-Ausch, et al.
Journal of Pathology Informatics|December 23, 2024
Towards interactive AI-authoring with prototypical few-shot classifiers in histopathologyPetr Kuritcyn, Rosalie Kletzander, Sophia Eisenberg, et al.
Wiener Klinische Wochenschrift|July 26, 2018
Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy managementMaria-Theresa Krauth, Sonja Burgstaller, Veronika Buxhofer-Ausch, et al.
JCO Precision Oncology|September 27, 2021
<i>STRN-ALK</i> Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential TherapyValeria Gerthofer, Alexander Scheiter, Florian Lüke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 27, 2011
Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II studyDietmar Ofner, Alexander F Devries, Renate Schaberl-Moser, et al.
Eclinicalmedicine|November 29, 2023
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trialFelix Keil, Antonia M S Müller, Andrea Berghold, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neckFelix Keil, Edgar Selzer, Andrea Berghold, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Investigation|June 20, 2014
Clofarabine/cyclophosphamide for debulking before stem cell transplantationWerner Rabitsch, Alexandra Böhm, Marija Bojic, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2021
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trialFelix Keil, Maximilian Hartl, Gabriela Altorjai, et al.
American Journal of Hematology|June 1, 2024
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALLKarin Bauer, Alexander Hauswirth, Karoline V Gleixner, et al.
Wiener Klinische Wochenschrift|December 14, 2018
Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy managementMaria-Theresa Krauth, Sonja Burgstaller, Veronika Buxhofer-Ausch, et al.
Journal of Pathology Informatics|December 23, 2024
Towards interactive AI-authoring with prototypical few-shot classifiers in histopathologyPetr Kuritcyn, Rosalie Kletzander, Sophia Eisenberg, et al.
Wiener Klinische Wochenschrift|July 26, 2018
Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy managementMaria-Theresa Krauth, Sonja Burgstaller, Veronika Buxhofer-Ausch, et al.
JCO Precision Oncology|September 27, 2021
<i>STRN-ALK</i> Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential TherapyValeria Gerthofer, Alexander Scheiter, Florian Lüke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 27, 2011
Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II studyDietmar Ofner, Alexander F Devries, Renate Schaberl-Moser, et al.
Eclinicalmedicine|November 29, 2023
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trialFelix Keil, Antonia M S Müller, Andrea Berghold, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neckFelix Keil, Edgar Selzer, Andrea Berghold, et al.
Pageof 9